广誉远股价震荡下行，中药行业政策利好或带来积极影响

Group 1 - The recent policy benefits for the traditional Chinese medicine industry may positively impact Guangyuyuan (600771) [1] - The Ministry of Industry and Information Technology and seven other departments issued the "Implementation Plan for High-Quality Development of Traditional Chinese Medicine Industry (2026-2030)" on February 12, 2026, outlining a five-year development blueprint [1] - The plan emphasizes the cultivation of high-standard raw material bases and promotes digital transformation, which aligns with Guangyuyuan's goals of brand protection and technological innovation [1] Group 2 - Guangyuyuan's stock price has shown a downward trend, closing at 17.73 yuan on February 13, 2026, down 1.99% from 18.23 yuan on February 9, 2026 [2] - The stock experienced a price fluctuation of 3.59% during this period, with a net outflow of 109.89 thousand yuan from institutional investors and a net inflow of 599.19 thousand yuan from retail investors on February 13, 2026 [2] - The technical analysis indicates that the stock is facing resistance at the 20-day pressure level of 18.44 yuan, with support around 17.58 yuan, and there are no significant reversal signals from indicators like MACD [2]